Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplant

J. Z. Wimperis, N. J. Berry, M. K. Brenner, J. Grundy, A. V. Hoffbrand, P. D. Griffiths, H. G. Prentice

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The serological status to cytomegalovirus (CMV) was examined in 24 patients with no detectable CMV excretion, following T-lymphocyte depleted bone marrow transplantation. The results show that seropositive recipients continue to produce CMV antibody regardless of the serological status of the donor but that seronegative recipients fail to produce CMV antibody even when the donor is seropositive. These findings suggest that when an effective CMV vaccine becomes available vaccination of the donor would be unlikely to confer protection on the recipient but that vaccination of the recipient may achieve this.

Original languageEnglish (US)
Pages (from-to)659-664
Number of pages6
JournalBritish Journal of Haematology
Issue number4
StatePublished - Aug 1986

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplant'. Together they form a unique fingerprint.

Cite this